Shares of Calumet, Inc. (NASDAQ:CLMT - Get Free Report) have earned a consensus rating of "Hold" from the seven research firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $54.75.
Several research analysts have recently issued reports on CLMT shares. Wall Street Zen upgraded shares of Calumet from a "hold" rating to a "buy" rating in a report on Saturday. Citigroup reaffirmed a "buy" rating on shares of Calumet in a research report on Monday, August 10th. UBS Group lifted their price target on shares of Calumet from $26.00 to $47.00 and gave the stock a "neutral" rating in a research note on Tuesday, August 25th. HC Wainwright boosted their price target on shares of Calumet from $60.00 to $75.00 and gave the company a "buy" rating in a research report on Wednesday, September 2nd. Finally, TD Cowen upped their price objective on shares of Calumet from $34.00 to $40.00 and gave the company a "hold" rating in a research note on Wednesday, August 12th.
Check Out Our Latest Stock Analysis on CLMT
Calumet Price Performance
Shares of CLMT opened at $34.30 on Monday. The stock has a 50 day moving average price of $51.86 and a 200 day moving average price of $39.34. The company has a market capitalization of $3.02 billion, a price-to-earnings ratio of -15.24, a price-to-earnings-growth ratio of 0.23 and a beta of 0.65. Calumet has a 52-week low of $17.85 and a 52-week high of $59.87.
Calumet (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings data on Friday, November 6th. The oil and gas company reported $2.91 earnings per share for the quarter, topping analysts' consensus estimates of $1.63 by $1.28. Calumet had a negative net margin of 3.73% and a negative return on equity of 32.93%. The company had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.34 billion. During the same quarter last year, the company earned $3.61 earnings per share. The firm's revenue for the quarter was up 56.1% on a year-over-year basis. On average, equities analysts anticipate that Calumet will post 3.09 EPS for the current fiscal year.
Institutional Trading of Calumet
A number of hedge funds and other institutional investors have recently made changes to their positions in CLMT. Two Seas Capital LP purchased a new position in Calumet during the 2nd quarter worth approximately $238,442,000. Bank of America Corp DE acquired a new position in Calumet during the second quarter worth approximately $35,348,000. Renaissance Technologies LLC purchased a new stake in Calumet in the first quarter valued at approximately $14,066,000. State Street Corp lifted its stake in Calumet by 12.7% in the second quarter. State Street Corp now owns 3,471,065 shares of the oil and gas company's stock valued at $125,028,000 after buying an additional 390,906 shares during the last quarter. Finally, Hennessy Advisors Inc. purchased a new stake in Calumet in the second quarter valued at approximately $10,201,000. Institutional investors and hedge funds own 34.41% of the company's stock.
Calumet Company Profile
(
Get Free Report)
Calumet, Inc. is a U.S.-based producer of specialty hydrocarbon products, renewable fuels and conventional fuels. Its products serve customers in industries such as manufacturing, transportation, energy and consumer goods. The company's specialty products include lubricating oils, solvents, waxes, petrolatums and asphalt. It also produces gasoline, diesel and other fuels, and through its Montana Renewables business makes lower-carbon fuels, including sustainable aviation fuel and renewable diesel.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calumet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.
While Calumet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.